UCT Clean Screen® DAU Cited in 3-Methylfentanyl Article

UCT Inc., is known around the world as the premier manufacturer of Solid Phase Extraction (SPE) sorbents. It’s support for analysts performing testing in the field of environmental sample testing for public protection has been a core activity for over thirty years. In a recent paper published in Environmental Science Water Research & Technology ((2016), 2, 502) by D.L.McCurry et al., UCT’s Enviro Clean^® activated carbon SPE columns were employed to extract and analyze NMDA from water.

For many forensic toxicologists, studying the biological pathways of illicit drugs is important if offering interpretation to the submitting agents. One of the most common drugs seen by forensic toxicologists on a routine basis is cocaine. The pharmacokinetic profile of oral cocaine has not been fully characterized and prospective data on oral bioavailability is limited. In a recent paper published in Journal of Analytical Toxicology (doi: 10.1093/jat/bky007) by Marion A.Coe, set al., a within-subject study was performed to characterize the bioavailability and pharmacokinetics of oral cocaine. This study was performed using UCT’s most famous solid phase extraction (SPE) sorbent Clean Screen DAU^®(ZSDAU020) to extract the compound and metabolites.

UCT would like to extend a special thanks to all of this year’s attendees at NACRW who paid visit to the booth and/or attended our sponsored lunch and learn focused on veterinary drug residue analysis. 

Of the challenges facing forensic toxicologists working in the post mortem field, the analysis of decomposed or skeletal remains for the presence and concentrations of drug compounds may be the most difficult. The use of bone as a matrix for toxicological analysis has been investigated extensively since 2000. These studies, involving both human and animal remains, have shown a wide variability in detected drug and metabolite levels across different bone types. Interpretation of toxicological measurements in bone is also complicated by the inability to properly determine analyte recovery from bone tissue. In a recent study published in Drug Testing and Analysis by H. M. Cornthwaite et al., (doi: 10.1002/dta.2327), UCT’s world famous Clean Screen FASt^® solid phase extraction sorbent in 96 well plate format (100 mg bed mass) was employed to extract tramadol (TRAM), dextromethorphan (DXM) and their respective metabolites from skeletal remains. 

UCT is known around the world for its support of clinical pharmacologists and their studies as they look for the finest sorbents to perform the extractions.  In a recent paper by Adam L. Halberstadt  (Department of Psychiatry, University of California San Diego), UCT’s flagship sorbent Clean Screen^® DAU (ZSDAU020) was employed in the study involving the interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine (Pharmacology, Biochemistry and Behavior (2016) 143 1–10).Monoamine oxidase inhibitors (MAOIs) are often ingested together with tryptamine hallucinogens, but relatively little is known about the consequences of their combined use.